{{Rsnum
|rsid=17647114
|Gene=AGBL1
|Chromosome=15
|position=86893514
|Orientation=plus
|GMAF=0.0303
|Gene_s=AGBL1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 4.7 | 95.3
| HCB | 0.0 | 3.0 | 97.0
| JPT | 0.0 | 0.9 | 99.1
| YRI | 0.0 | 24.0 | 76.0
| ASW | 1.8 | 17.5 | 80.7
| CHB | 0.0 | 3.0 | 97.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.9 | 18.3 | 80.7
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.7 | 15.7 | 83.7
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22041458
|Trait=None
|Title=Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.
|RiskAllele=T
|Pval=4E-7
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}